| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $134K | -79.2% |
| Cost of Revenue | $627K | -17.1% |
| Gross Profit | -$493K | -342.0% |
| R&D Expense | $10.9M | +53.9% |
| SG&A Expense | $16.3M | -12.5% |
| Operating Income | -$27.9M | -6.9% |
| Pre-tax Income | -$35.0M | -8.1% |
| Net Income | -$40.4M | -24.6% |
| EPS (Basic) | -$3062.51 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $833K | +757.9% |
| Accounts Receivable | $43K | -89.4% |
| Inventory | $11K | -98.5% |
| Current Assets | $2.0M | -71.1% |
| Total Assets | $32.1M | -27.9% |
| Current Liabilities | $23.4M | -9.6% |
| Total Liabilities | $23.9M | -16.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | +9.8% |
| Investing Cash Flow | -$5.0M | — |
| Financing Cash Flow | $22.5M | +41.3% |
| -2731.7% |
| EPS (Diluted) | -$3062.51 | -2731.7% |
| Stockholders' Equity |
| $497K |
| -96.9% |